Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data: The Finnish example

Abstract

<jats:p> This paper presents the principles of implementing register-based cohort studies as currently applied for real-time estimation of influenza vaccine effectiveness in Finland. All required information is retrieved from computerised national registers and deterministically linked via the unique personal identity code assigned to each Finnish resident. The study cohorts comprise large subpopulations eligible for a free seasonal influenza vaccination as part of the National Vaccination Programme. The primary outcome is laboratory-confirmed influenza. Each study subject is taken to be at risk of experiencing the outcome from the onset of the influenza season until the first of the following three events occurs: outcome, loss to follow up or end of season. Seasonal influenza vaccination is viewed as time-dependent exposure. Accordingly, each subject may contribute unvaccinated and vaccinated person-time during their time at risk. The vaccine effectiveness is estimated as one minus the influenza incidence rate ratio comparing the vaccinated with the unvaccinated within the study cohorts. Data collection in register-based research is an almost fully automated process. The effort, resources and the time spent in the field are relatively small compared to other observational study designs. This advantage is pivotal when vaccine effectiveness estimates are needed in real time. The paper outlines possible limitations of register-based cohort studies. It also addresses the need to explore how national and subnational registers available in the Nordic countries and elsewhere can be utilised in vaccine effectiveness research to guide decision making and to improve individual health as well as public health. </jats:p>

Effectiveness of Mass Vaccination in Brazil against Severe COVID-19 Cases

“…The methodology here has advantages over the Screening method, described in WHO guidelines (8), due to the use of rate ratios and stratification by age groups and states, a sound approach given the variability of incidences across a large country such as Brazil. In addition, it is similar to evaluation methods of other vaccination programs such as Influenza (9). Effectiveness estimates of ChAdOx1 nCov-19 in Brazil are compatible with prior findings on its efficacy and prior effectiveness.…”

Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study

“…The main strengths of this analysis are the size and representativeness of the two cohorts and the register-based nature of the study [ 28 ]. In Finland, the recording of Covid-19 vaccinations into the patient information system is mandatory, as is the notification of SARS-CoV-2 positive laboratory findings.…”

Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20

“…The Care Register for Health Care and the Finnish Infectious Diseases Register provided diagnostic information and laboratory-confirmed data. A detailed description of these data sources and linkage can be found elsewhere [ 4 ].…”

“…For each season, we conducted a register-based cohort study to estimate IVE [ 4 ]. The study cohort consisted of the population aged 65–100 years (see Supplementary Table S1 for the inclusion/exclusion criteria).…”

“…Assuming that influenza vaccination provides partial protection for the vaccinated, an appropriate measure of the protective direct effect under real-life conditions is influenza vaccine effectiveness (IVE) defined as the vaccine-attributable relative reduction in the hazard of influenza disease [ 2 , 3 ]. To guide public health measures as well as individual-level decision-making, IVE in elderly people is estimated regularly in Finland using a register-based cohort study design [ 4 ].…”